Anavex Life Sciences Corp (AVXL)
3.445
+0.04
(+1.03%)
USD |
NASDAQ |
Apr 25, 11:55
Anavex Life Sciences Shareholders Equity (Quarterly): 135.58M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 135.58M |
September 30, 2023 | 141.85M |
June 30, 2023 | 146.75M |
March 31, 2023 | 145.17M |
December 31, 2022 | 135.12M |
September 30, 2022 | 142.49M |
June 30, 2022 | 150.74M |
March 31, 2022 | 152.20M |
December 31, 2021 | 146.37M |
September 30, 2021 | 150.82M |
June 30, 2021 | 157.15M |
March 31, 2021 | 75.81M |
December 31, 2020 | 46.30M |
September 30, 2020 | 27.24M |
June 30, 2020 | 24.68M |
March 31, 2020 | 24.79M |
December 31, 2019 | 25.96M |
September 30, 2019 | 20.29M |
June 30, 2019 | 17.63M |
March 31, 2019 | 14.18M |
December 31, 2018 | 17.22M |
September 30, 2018 | 22.32M |
June 30, 2018 | 23.59M |
March 31, 2018 | 22.48M |
December 31, 2017 | 25.55M |
Date | Value |
---|---|
September 30, 2017 | 24.25M |
June 30, 2017 | 23.45M |
March 31, 2017 | 21.49M |
December 31, 2016 | 19.18M |
September 30, 2016 | 6.308M |
June 30, 2016 | 7.671M |
March 31, 2016 | 9.683M |
December 31, 2015 | 11.49M |
September 30, 2015 | 12.81M |
June 30, 2015 | 6.569M |
March 31, 2015 | 4.702M |
December 31, 2014 | 0.4731M |
September 30, 2014 | 0.1926M |
June 30, 2014 | 7.409M |
March 31, 2014 | 8.408M |
December 31, 2013 | -1.670M |
September 30, 2013 | -2.463M |
June 30, 2013 | -3.553M |
March 31, 2013 | -3.435M |
December 31, 2012 | -3.329M |
September 30, 2012 | -2.875M |
June 30, 2012 | -2.198M |
March 31, 2012 | -2.928M |
December 31, 2011 | -2.481M |
September 30, 2011 | -1.142M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
17.63M
Minimum
Jun 2019
157.15M
Maximum
Jun 2021
98.26M
Average
135.58M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
Ventyx Biosciences Inc | 243.92M |
Checkpoint Therapeutics Inc | -13.05M |
Vertex Pharmaceuticals Inc | 17.58B |
Sarepta Therapeutics Inc | 859.34M |
NovaBay Pharmaceuticals Inc | 3.314M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 148.07M |
Total Liabilities (Quarterly) | 12.50M |